Prognostic Values of SUVmax Value of PET/CT and CA19-9 as biologic markers in Patients with Pancreatic Ductal Adenocarcinoma

MLA

W. Kwon, et al. “Prognostic Values of SUVmax Value of PET/CT and CA19-9 as Biologic Markers in Patients with Pancreatic Ductal Adenocarcinoma.” Pancreatology, vol. 20, Nov. 2020, p. S151. EBSCOhost, https://doi.org/10.1016/j.pan.2020.07.288.

APA

W. Kwon, Yoojin Choi, Youngmin Han, Jin-Young Jang, D. Moon, Jae Seung Kang, Hongbeom Kim, & Y. Byun. (2020). Prognostic Values of SUVmax Value of PET/CT and CA19-9 as biologic markers in Patients with Pancreatic Ductal Adenocarcinoma. Pancreatology, 20, S151. https://doi.org/10.1016/j.pan.2020.07.288

Chicago

W. Kwon, Yoojin Choi, Youngmin Han, Jin-Young Jang, D. Moon, Jae Seung Kang, Hongbeom Kim, and Y. Byun. 2020. “Prognostic Values of SUVmax Value of PET/CT and CA19-9 as Biologic Markers in Patients with Pancreatic Ductal Adenocarcinoma.” Pancreatology 20 (November): S151. doi:10.1016/j.pan.2020.07.288.